An epigenomic-profiling study of prostate cancer tumors noted that CACNA1D was among the top-ten-ranked differentially-methylated (hypomethylated) genes in tissues with ERG fusion, compared to those without [103]. This evidence concerns the gene CACNA1D and prostate cancer.